Amaryl tablets (glimepiride) - Revised SPC

Source: eMC (electronic Medicines Compendium)

Date published: 01/02/2010 11:39

Type of SPC Change: Revised SPC

Generic drug name: Glimepiride

Drug brand name: Amaryl

Legal status: POM

Pharmaceutical manufacturer: Sanofi Aventis

Summary
by: Clare Greenwood

Change to section 4.8 - Undesirable Effects:

Category of 'Not known' added to the following effects:

  • Cross-allergenicity with sulfonylureas, sulfonamides or related substances is possible.
  • Visual disturbances, transient, may occur especially on initiation of treatment, due to changes in blood glucose levels.
  • Hepatic enzymes increased
  • Hypersensitivity reactions of the skin may occur as pruritus, rash, urticaria and photosensitivity.
SPC

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.